Search
Select region
Close filter
Industries

Health

A foundational shift is under way in the global health space, thanks to continuous disruptions and groundbreaking innovations. Legacy organizations are embracing change, testing novel business models, and creating new opportunities. At the same time, new players from technology, consumer products, services, and other sectors are entering the enormous global health marketplace, unburdened by conventional business models.

In this new world of convergence, health systems in both established and emerging markets are seeking new ways to meet the demands of diverse populations. At the same time, it is becoming increasingly difficult to draw lines separating technology, science, and medicine. Information and technology-enabled consumers are also fueling change, disrupting traditional ties between life-science companies, providers, payers, and patients.

This means that companies need a new kind of leadership. At Egon Zehnder, our Health Practice finds and develops leaders from across industries and geographies with the ability to catalyze change across an entire organization. With our global reach of 63 offices and deep industry experience, we are able to actively advise organizations that are breaking new ground and realigning for this new patient-centric health model.

Find a Consultant

Health Consultants

Emanuela Cancogni

Emanuela Cancogni

Milan

Global Lead

Based in Milan, Emanuela Cancogni is the Global co-Leader of the Health Practice. She is a trusted advisor to clients in Health (Pharma, Diagnostics… Read more

Kevin Jia-Ven Lai

Kevin Jia-Ven Lai

Singapore

Global Lead

Kevin Lai, based in Singapore, is the Global Health Practice Co-Leader. He is deeply experienced within the health sector, with more than 16 years of… Read more

Jessica Watson

Jessica Watson

Washington, D.C.

US Lead

Jessica Watson is one of the co-founders of Egon Zehnder’s Washington, DC office and currently leads the firm’s Health Practice for the Americas… Read more

Christina Ng

Christina Ng

Washington, D.C.

Based in Washington, D.C., Christina Ng is active in Egon Zehnder’s Health Practice and Public & Social Sector Practice. A seasoned senior leader and… Read more

Alyse Forcellina

Alyse Forcellina

New York

Alyse Forcellina is an experienced partner who has led Egon Zehnder’s US Health and Leadership Advisory Practices, and is also active in the firm’s… Read more

Andrea Kilpatrick

Andrea Kilpatrick

New York

Andrea is a leader in Egon Zehnder’s Media, Entertainment and Sports Practice where she leads the firm’s work with “creators”. Partnering with the… Read more

Lee Wrubel, MD

Lee Wrubel, MD

New York

Lee Wrubel, based in New York, is Co-Lead of the Global Healthcare Research and Development Group and works broadly with organizations driving… Read more

Stephanie Levitt

Stephanie Levitt

New York

Stephanie Levitt is active in Egon Zehnder’s Health Practice, with a primary focus on the convergence of technology, health care and consumer… Read more

Peter Gallagher

Peter Gallagher

New York

Peter Gallagher, based in New York, is a core member of Egon Zehnder’s Health Practice. Drawing on diverse biopharma industry experience in… Read more

Kshitij Mohta

Kshitij Mohta

New York

Kshitij Mohta, based in New York, operates at the intersection of Health and private equity, working both with growth equity and large, multinational… Read more

Jennifer Power

Jennifer Power

New York

Based in New York, Jennifer Power is active in Egon Zehnder’s Healthcare Practice. Read more

Tim McNicholas

Tim McNicholas

Boston Office Leader

Tim McNicholas is the Managing Partner of Egon Zehnder’s Boston office and leads our Human Resource practice in the United States. Read more

Greig Schneider

Greig Schneider

Boston

Greig Schneider, based in Boston, leads the firm’s Leadership Advisory practice. He was Egon Zehnder’s U. S. Managing Partner from 2010 to 2016 and… Read more

Simmi Singh

Simmi Singh

Chicago, Washington, D.C.

Simmi Singh is based in Egon Zehnder’s Chicago office, and in her decade with the Firm, has played a founding and leadership role in the Firm’s… Read more

Douglas Kush

Douglas Kush

Chicago

Doug Kush is a Partner in the Chicago office of Egon Zehnder. While at Egon Zehnder, he has held multiple leadership roles including Global Head of… Read more

Marwa Zohdy

Marwa Zohdy

Chicago

Based in Chicago, Marwa Joy Zohdy is an active member of Egon Zehnder’s global Health Practice. Read more

Case Studies

Redefining Health Leadership

See how we help companies at the forefront of change and convergence build successful leadership teams.

Read more

Thought Leadership | Health

Read more insights
Engaging and Influencing Your Board in an Age of Rapid Change: Biopharma CTOs Share Their Best Practices

Engaging and Influencing Your Board in an Age of Rapid Change: Biopharma CTOs Share Their Best Practices

Egon Zehnder recently invited CTOs from top U.S. biopharma companies to discuss their experiences and best practices in today’s rapidly changing environment Read more

The Future of Talent Management in Biopharma

The Future of Talent Management in Biopharma

Biopharma HR leaders share how they are taking a fresh look at developing and engaging their leaders as we emerge from the pandemic. Read more

Confronting the Challenge of Attracting and Retaining African Scientists to the Continent

Confronting the Challenge of Attracting and Retaining African Scientists to the Continent

Egon Zehnder partnered with the UK Medical Research Council to interview 15 African biomedical scientists and ask why they work elsewhere. Read more

In for the Long Haul: Biotechs Address the Issues Presented by the Extended Pandemic

In for the Long Haul: Biotechs Address the Issues Presented by the Extended Pandemic

Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic. Read more

Biotech During a Pandemic: Addressing Challenges Along the Pharma Value Chain

Biotech During a Pandemic: Addressing Challenges Along the Pharma Value Chain

European Biotech leaders reveal to Egon Zehnder that people are becoming much more comfortable and efficient at using virtual meetings. Read more

The ‘New Normal’ for Biopharma

The ‘New Normal’ for Biopharma

Egon Zehnder virtually gathered 15 top HR leaders across biopharma who shared how COVID-19 made them rethink some aspects of their businesses. Read more

European Biotech CEOs Navigate Towards a “New Normal

European Biotech CEOs Navigate Towards a “New Normal" Pt 2

Highlights from the fourth round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

Coronavirus – Learnings and Takeaways from Small Biotech

Coronavirus – Learnings and Takeaways from Small Biotech

Highlights from the second round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

European Biotech CEOs Navigate Towards a “New Normal” Pt 1

European Biotech CEOs Navigate Towards a “New Normal” Pt 1

Highlights from the third round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder. Read more

A Generation of Medicines at Risk

A Generation of Medicines at Risk

Senior Biotech R&D execs brainstorm on saving clinical trials, modifying procedures, and getting people back to work. Read more

The Outlook from Biopharma Commercial Leaders: What to Expect Next

The Outlook from Biopharma Commercial Leaders: What to Expect Next

Egon Zehnder's lessons from how the biopharma industry has responded to Covid-19 with focus, collaboration and resilience. Read more

Risk and Opportunity: Healthcare Leaders in Asia Reflect on Post COVID-19 Recovery

Risk and Opportunity: Healthcare Leaders in Asia Reflect on Post COVID-19 Recovery

Healthcare CEOs in Asia have embraced that duality and in a teleconference organized by Egon Zehnder, they gathered to discuss the fallout from COVID-19. Read more

Changing language
Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top